Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Feb 14;8(2):191-193.
doi: 10.1016/j.stemcr.2017.01.024.

Lessons Learned from Pioneering Neural Stem Cell Studies

Sally Temple  1 , Lorenz Studer  2
Affiliations
Comment

Lessons Learned from Pioneering Neural Stem Cell Studies

Sally Temple et al. Stem Cell Reports. .

Abstract

As stem cell products are increasingly entering early stage clinical trials, we are learning from experience about how cell products may be best assessed for safety and efficacy. In two papers published in this issue of Stem Cell Reports, a human neural stem cell product, HuCNS-SC, failed to demonstrate efficacy in central nervous system repair in two different animal models (Anderson et al., 2017; Marsh et al., 2017), although closely related research-grade cell products showed evidence of efficacy. This indicates the need for increased cell characterization to determine comparability of lots proposed for pre-clinical and clinical use. Without such improvements, pre-clinical data supporting a clinical study might not adequately reflect the performance of subsequent batches of cells intended for use in patients.

PubMed Disclaimer

Comment on

References

    1. Ager R.R., Davis J.L., Agazaryan A., Benavente F., Poon W.W., LaFerla F.M., Blurton-Jones M. Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer’s disease and neuronal loss. Hippocampus. 2015;25:813–826. - PMC - PubMed
    1. Anderson A.J., Cummings B.J. Achieving informed consent for cellular therapies: a preclinical translational research perspective on regulations versus a dose of reality. J. Law Med. Ethics. 2016;44:394–401. - PMC - PubMed
    1. Anderson A.J., Piltti K.M., Hooshmand M.J., Nishi R.A., Cummings B.J. Preclinical efficacy failure of human CNS-derived stem cells for use in the pathway study of cervical spinal cord injury. Stem Cell Reports. 2017;8:249–263. this issue. - PMC - PubMed
    1. Daley G.Q., Hyun I., Apperley J.F., Barker R.A., Benvenisty N., Bredenoord A.L., Breuer C.K., Caulfield T., Cedars M.I., Frey-Vasconcells J. Setting global standards for stem cell research and clinical translation: the 2016 ISSCR guidelines. Stem Cell Reports. 2016;6:787–797. - PMC - PubMed
    1. International Society for Stem Cell Research (2016). Guidelines for Stem Cell Research and Translation. http://www.isscr.org/guidelines2016.